toviaz 4 mg
pfizer pharmaceuticals israel ltd - fesoterodine fumarate - tablets sustained release - fesoterodine fumarate 4 mg - fesoterodine - fesoterodine - treatment of the symptoms (increased urinary frequency and/or urgency and/or urgency incontinence) that may occur in patients with overactive bladder syndrome.
toviaz 8 mg
pfizer pharmaceuticals israel ltd - fesoterodine fumarate - tablets sustained release - fesoterodine fumarate 8 mg - fesoterodine - fesoterodine - treatment of the symptoms (increased urinary frequency and/or urgency and/or urgency incontinence) that may occur in patients with overactive bladder syndrome.
mingocare 4 mg prolonged-release tablets
ceres pharma - fesoterodine fumarate - prolonged-release tablet - fesoterodine
mingocare 8 mg prolonged-release tablets
ceres pharma - fesoterodine fumarate - prolonged-release tablet - fesoterodine
fesoterodine ab 4 mg tabl. prol.-rel.
aurobindo sa-nv - fesoterodine fumarate 4 mg - eq. fesoterodine 3,1 mg - prolonged-release tablet - fesoterodine
fesoterodine ab 8 mg tabl. prol.-rel.
aurobindo sa-nv - fesoterodine fumarate 8 mg - eq. fesoterodine 6,2 mg - prolonged-release tablet - fesoterodine
fesoterodine 4mg modified-release tablets
aspire pharma ltd - fesoterodine fumarate - modified-release tablet - 4mg
fesoterodine 8mg modified-release tablets
aspire pharma ltd - fesoterodine fumarate - modified-release tablet - 8mg
fesoterodine 4mg modified-release tablets
aristo pharma ltd - fesoterodine fumarate - modified-release tablet - 4mg
fesoterodine 8mg modified-release tablets
aristo pharma ltd - fesoterodine fumarate - modified-release tablet - 8mg